|
|
ChemGenex Pharmaceuticals Limited - Sales Analysis Snapshot
Business Description This Report provides a comprehensive Sales & Margin summary analysis for ChemGenex Pharmaceuticals Limited Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
ChemGenex Pharmaceuticals Limited. The Group's principal activity is operating as an integrated biopharmaceutical development company, focused on discovering and developing oncology drugs. Its product candidates include omacetaxine mepesuccinate (formerly known as Ceflatonin, homoharringtonine or HHT), which is and Quinamed (amonafide dihydrochloride). Operations are carried out in Australia and the United States of America.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|